Company intelligence / Profile preview

FanninDirect investor group

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

FanninDirect is a direct-investment platform and investor group affiliated with Fannin (Fannin Innovation Studio/Fannin Partners) that co-invests, via special purpose vehicles, in early‑stage bioscience companies and spinouts from Fannin’s Houston-based life science development studio.[1][4][12] It is an investor, not a drug developer, so it has no own clinical pipeline.

Industry: Investors

Partnerships

Fannin Innovation StudioFannin PartnersPortfolio companies such as Procyrion, Pulmotect, Allterum Therapeutics, Brevitest Technologies[1][4][5]

Beyond the preview

Go deeper on FanninDirect investor group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FanninDirect investor group.

Explore the full profile